Purpose: To report long-term pulmonary, thyroid, and ocular complications i
n patients who had conditioning regimens including total body if radiation
(TBI) before bone marrow transplantation (BMT).
Methods and Materials: Between June 1986 and December 1995, 478 patients re
ceived TBI in our institution. The present study includes 186 adult patient
s who had complete remission lasting one year or more after BMT. There were
108 males and 78 females. Median age was 36.5 years (range 15-60). Initial
diagnoses were lymphomas (50%), acute lymphoid leukemias (16%), acute myel
oid leukemias (16%), chronic myeloid leukemia (13%), aplastic anemia (3%),
and myelodysplasia (2%). At the time of BMT, 43.5% of patients were in comp
lete response and 56.5% in partial response. Treatment consisted of a singl
e dose TBI at 10 Gy in 9% and fractionated TBI delivering 12 to 13.5 Gy in
6 fractions in 91%. From 1986 to October 1991, TBI was performed in lateral
position with 9 MV energy (57% of patients) and thereafter in alternate pr
one and supine positions with 15 MV energy (43%). Chemical conditioning reg
imen was cyclophosphamide (60 mg/kg at D-4 and D-3) in 69% and CBV (cycloph
osphamide 1500 mg/m(2) from D-6 to D-3, BCNU 300 mg/m(2) at D-6, VP-16 200
mg/m(2) from D-6 to D-4) in 25%. Fifty eight percent of patients received a
utologous and 42% allogeneic BMT. All patients had clinical, biologic, and
functional examinations at one-year intervals.
Results: Median follow-up from BMT was 49 months (range 12-136). Late pulmo
nary effects were observed only in functional explorations, without clinica
l effect, including restrictive syndrome in 8% and alteration in the diffus
ing capacity of carbon monoxide in 12%. No patient showed clinical thyroid
symptoms, and 10% developed biologic dysfunction: hypothyroidism (6.5%), th
yroiditis (3%), and Basedow disease (0.5%). Ocular complications occurred i
n 29.5%, including cataract (15%), dry syndrome (13%), and keratitis (1.5%)
. In univariate and multivariate analysis, pulmonary complications were sta
tistically increased by chronicle graft vs. host disease (GVHD) vs. no (p =
0.02), prone and supine vs. lateral TBI position (p = 0.02), and with 15 M
V vs. 9 MV beam energy (p = 0.02), Cataract occurred less frequently with f
ractionated than with single-dose TBI (p = 0.000002). No differences were o
bserved regarding age, sex, initial diagnosis, status at the time of BMT, c
onditioning chemotherapy regimen, and total dose of TBI.
Conclusion: From this retrospective study it was shown that long-term compl
ications of TBI were not symptomatic in most patients. The role of paramete
rs of irradiation and especially position of treatment and beam energy shou
ld be emphasized and assessed with a longer follow-up. (C) 2001 Elsevier Sc
ience Inc.